The First Case of Biological Therapy Discontinuation After a Complete Remission Induced by Maintenance Therapy With Adalimumab for Refractory Ulcerative Colitis

A 43-year-old woman, diagnosed with ulcerative colitis (UC) at age of 30, received outpatient treatment with corticosteroids. However, flare-up occurred, and adalimumab (ADA) treatment commenced in July 2009. A complete remission with mucosal healing was achieved by 32 weeks after initiation of ADA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanida, Satoshi, Mizoshita, Tsutomu, Ozeki, Keiji, Tsukamoto, Hironobu, Mori, Yoshinori, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245064/
https://www.ncbi.nlm.nih.gov/pubmed/25436030
http://dx.doi.org/10.14740/jocmr1991w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245064/
https://www.ncbi.nlm.nih.gov/pubmed/25436030
http://dx.doi.org/10.14740/jocmr1991w

Ejemplares similares